BlackRock, Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 2012383 New York, NY

Position in GILD

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$15,393,784,591

-$1,192,774,700 QoQ

Shares Held

121,844,108

+2.4% QoQ

Ownership

9.83%

of shares outstanding

% of Portfolio

0.24%

of 13F equity value

Holder Rank

of 2,266 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $263,330,305,956 across 19 Drug Manufacturers - General names. GILD ranks #6 (5.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	67,540,400	$81,009,988,717
2	JNJ	Johnson & Johnson	212,098,264	$53,866,596,097
3	ABBV	AbbVie Inc.	149,488,412	$37,617,263,984
4	MRK	Merck & Co., Inc.	226,999,837	$29,169,479,049
5	AMGN	Amgen Inc	49,362,016	$17,874,973,223
6	GILD	Gilead Sciences, Inc. This page	121,844,108	$15,393,784,591
7	PFE	Pfizer Inc	529,670,433	$12,754,464,016
8	BMY	Bristol Myers Squibb Co	180,384,994	$10,393,783,345

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,393,784,591	121,844,108	+2.4%	Shares	Sole	2026-08-07
2026-03-31	$16,586,559,291	119,010,973	-3.4%	Shares	Sole	2026-05-13
2025-12-31	$15,121,025,232	123,195,578	+5.9%	Shares	Sole	2026-02-12
2025-09-30	$12,907,234,401	116,281,391	+1.2%	Shares	Sole	2025-11-12
2025-06-30	$12,736,736,940	114,879,922	-1.1%	Shares	Sole	2025-08-12
2025-03-31	$13,009,517,282	116,104,572	-3.5%	Shares	Sole	2025-05-02
2024-12-31	$11,117,269,021	120,355,841	-1.3%	Shares	Sole	2025-02-07
2024-09-30	$10,223,096,957	121,935,794	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.